1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. CSL Limited
  6. News
  7. Summary
    CSL   AU000000CSL8

CSL LIMITED

(CSL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CSL Closes $4.5 Billion Share Placement; to Open Share Purchase Plan; Shares Sink 8%

12/16/2021 | 12:07am EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
CSL LIMITED 0.82% 271.64 Delayed Quote.-5.89%
VIFOR PHARMA AG -1.80% 169.5 Delayed Quote.4.47%
All news about CSL LIMITED
05/23Australian shares subdued as tech, healthcare offset mining gains
RE
05/11Australia shares slide as U.S. inflation data fuels slowdown woes
RE
05/11Australian shares rise on healthcare, mining boost; U.S. inflation data in focus
RE
05/06Australia shares slump as inflation woes hint at more rate hikes
RE
04/20CSL Prices $4 Billion of Bonds in US Debt Market
MT
04/20PAUL RAMSAY : KKR-led group offers record $14.8 billion bid for Australia's Ramsay Health
RE
03/31Australia shares inch lower on tech, energy losses
RE
03/29CSL Behring - European Medicines Agency Commences Review of Novel Gene Therapy Candidat..
AQ
03/28Seqirus Receives Health Canada Approval for Expanded Age Indication of Its Cell-Based Q..
AQ
03/23CSL BEHRING AG - PUBLICATION OF PROV : Participation rate of 94 percent
AQ
More news
Analyst Recommendations on CSL LIMITED
More recommendations
Financials (USD)
Sales 2022 10 734 M - -
Net income 2022 2 273 M - -
Net Debt 2022 7 484 M - -
P/E ratio 2022 39,3x
Yield 2022 1,09%
Capitalization 92 001 M 92 001 M -
EV / Sales 2022 9,27x
EV / Sales 2023 7,50x
Nbr of Employees 25 000
Free-Float 95,0%
Chart CSL LIMITED
Duration : Period :
CSL Limited Technical Analysis Chart | CSL | AU000000CSL8 | MarketScreener
Technical analysis trends CSL LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 190,98 $
Average target price 223,45 $
Spread / Average Target 17,0%
EPS Revisions
Managers and Directors
Paul Roger Perreault Chief Executive Officer, Executive Director & MD
Joy Carolyn Linton Chief Financial Officer
Brian Anthony McNamee Chairman
William Mezzanotte Chief Medical Officer, EVP & Head-R&D
Mark Hill Chief Digital Information Officer
Sector and Competitors
1st jan.Capi. (M$)
CSL LIMITED-5.89%93 252